MedPath

iPhone App Compared to Standard RR-measurement

Not Applicable
Completed
Conditions
Hypertension
Blood Pressure
Interventions
Device: cuff device (Omron HBP-1300-E Pro)
Device: iPhone 4s
Registration Number
NCT02552030
Lead Sponsor
Jens Eckstein
Brief Summary

In this Trial we compare a new application (App) running on an iPhone (Apple inc., Model 4S) to determine systolic blood pressure (RR) and compare it to conventional oscillometric measurements using an Omron HBP-1300-E Pro device. We will include 1000 participants and perform seven repetitive blood pressure measurements (3 iPhone, 4 Omron) in each person. Primary parameter will be the absolute difference (Delta) between the correlating blood pressure measurements in mmHg.

Detailed Description

Participants will be asked for consent at the University Hospital Basel at random based on availability. Recruitment is not limited to patients. After consenting patients will accompanied to a RR-measurement unit, positioned in a chair and kept at rest for 4 minutes. Then 7 blood pressure measurements at the same arm will be performed (Cuff/iPhone/Cuff/iPhone/Cuff/iPhone/Cuff). The Cuff measurement results will be documented in the source documents (mmHg) and transferred to a trial database. The iPhone data will be transferred with patient ID to "Preventicus" for calculation of the systolic blood pressure values (mmHg) based on the pulse waves recorded by transillumination of the index fingers of the participants. "Preventicus" will have NO access to the Cuff-measurement data. Then this data will be retransferred to the trial site and merged with help of the patient ID. Absolute and relative differences of the measured (Omron) and calculated (iPhone) systolic blood pressure values (mmHg) for will be calculated and published.

A subgroup of 40 participants will be evaluated in a highly standardized fashion according the ESH (European Society Hypertension) guidelines for validation studies. These data will then be published separately for validation purposes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1019
Inclusion Criteria
  • able to give informed consent
  • in Sinus rhythm
  • no anatomical limitation to take blood pressure
Exclusion Criteria
  • Atrial fibrillation
  • Dialysis shunt

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Blood pressure-measurementiPhone 4sSeven repetitive blood pressure measurements will be performed the left or right arm of all participants with an iPhone 4s and a conventional oscillometric device 'cuff device (Omron HBP-1300-E Pro)'
Blood pressure-measurementcuff device (Omron HBP-1300-E Pro)Seven repetitive blood pressure measurements will be performed the left or right arm of all participants with an iPhone 4s and a conventional oscillometric device 'cuff device (Omron HBP-1300-E Pro)'
Primary Outcome Measures
NameTimeMethod
Absolute difference between systolic blood pressure values determined with an oscillometric cuff device and an iPhone 4s (Delta mmHg)1 day

In each participant seven repetitive blood pressure measurements will be performed. Starting with a conventional cuff measurement followed by an iPhone measurement, followed by a conventional cuff measurement and so on. Then the absolute difference between each pair of successive measurements will be calculated. These differences will then be averaged and documented as primary result.

Secondary Outcome Measures
NameTimeMethod
Relative difference between oscillometric blood pressure measurement and iPhone based blood pressure measurement1 day

Same as primary outcome, but calculation of delta (mmHg) and documentation as relative value (%) of the absolute systolic value.

Percent of invalid measurements1 day

Percent of measurements that cannot be used for analysis

Comparison of primary outcome in the subgroup of patients with atherosclerosis compared to the participants without arteriosclerosis.1 day

Quantitative differences between the accuracy of the iPhone measurements in the patients with known arteriosclerosis and the patients without arteriosclerosis

Trial Locations

Locations (1)

Universityhospital

🇨🇭

Basel, BS, Switzerland

© Copyright 2025. All Rights Reserved by MedPath